Financial Daily from THE HINDU group of publications
Wednesday, Feb 15, 2006


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Corporate - Announcements
Markets - Stocks
Money & Banking - Life Insurance


LIC sells 2.18 pc stake in Dr Reddy's

Our Bureau

Hyderabad , Feb. 14

DR Reddy's Laboratories Ltd has informed the stock exchanges that Life Insurance Corporation of India has sold 16,67,144 shares aggregating to 2.18 per cent of share capital of Dr Reddy's Labs on January 30. The mode of sale is market sale. Following this, the shareholding of LIC in Dr Reddy's Labs now stands at 51,86,496 shares aggregating to 6.77 per cent of Dr Reddy's equity.

More Stories on : Announcements | Stocks | Life Insurance | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
IVRCL Infrastructure bags Rs 265-cr orders


LIC sells 2.18 pc stake in Dr Reddy's
Riddhi Siddhi to issue shares to Roquette Freres
HC begins hearing on Birlas' plea
NTPC to raise $ 1 b in debt
Mahindra to raise $200 m
Global eco certification
HLL back in the driver's seat
New management programme to let students get exposure to industry
Reliance Private Equity picks up 44 pc stake in DTDC for Rs 70 cr
United Phosphorus buys Dutch seed firm for 100 m euros
Wockhardt to raise up to $500 m for acquisitions abroad — Q4 net dips 23 pc to Rs 51 cr
Colour Chem acquires Chemtreat
GRT Regency to expand to smaller towns in South
Hatsun Agro expands capacity to target export markets
Bharat Bio says clinical trials on rotavirus vaccines encouraging
Miditech to launch new reality show formats
HLL: Cost-cutting exercise to continue
Suzuki chief ferries Japanese dealers on `incentive' trip to India



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line